2.165
price down icon0.69%   -0.015
 
loading

Finanzdaten der In 8 Bio Inc-Aktie (INAB)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
2.73%
0.107
0.11 0.064 0.023 0.06
Operating Expenses
8.11%
5.201
5.66 6.224 7.109 8.689
Benefits Costs and Expenses
8.11%
5.201
5.66 11.78 7.109 8.689
Costs And Expenses
8.11%
5.201
5.66 6.224 7.109 8.689
Operating Income/Loss
8.22%
-5.094
-5.55 -6.16 -7.086 -8.629
Income/Loss From Continuing Operations Before Tax
8.22%
-5.094
-5.55 -11.71 -7.086 -8.629
Income/Loss From Continuing Operations After Tax
8.22%
-5.094
-5.55 -6.16 -7.086 -8.629
Net Income/Loss
8.22%
-5.094
-5.55 -6.16 -7.086 -8.629
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
95.07%
4.1192
83.48 7.8564 47.32 45.13
Diluted Average Shares
95.07%
4.1192
83.48 7.8564 47.32 45.13
Basic Earnings Per Share
1,671%
-1.24
-0.07 -0.04 -0.15 -0.19
Diluted Earnings Per Share
1,671%
-1.24
-0.07 -0.04 -0.15 -0.19
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):